Appointment booking for Dr. Denis Privalov, MD is currently not available.Dr. Denis Privalov, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Denis Privalov, MD (he/him) is a Nephrologist in Salem, OR with over 19 years of experience. What is your opinion of Dr. Denis Privalov, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Denis Privalov, MD has received over $917 which includes payments from the following companies:
$190.81 from Amgen Inc.
$129.60 from Genentech USA, Inc.
$126.41 from Otsuka America Pharmaceutical, Inc.
$62.06 from Keryx Biopharmaceuticals, Inc.
$58.45 from Mallinckrodt LLC
$56.75 from AstraZeneca Pharmaceuticals LP
$44.23 from Daiichi Sankyo Inc.
$42.63 from Questcor Pharmaceuticals
$37.59 from Baxter Healthcare
$32.34 from Horizon Pharma plc
$31.87 from Alexion Pharmaceuticals, Inc.
$31.27 from Relypsa, Inc.
$16.67 from Fresenius USA Marketing, Inc.
$14.41 from AngioDynamics, Inc.
$14.20 from Otsuka Pharmaceutical Development & Commercialization, Inc.
$12.83 from Takeda Pharmaceuticals America, Inc.
$11.76 from Strongbridge US INC.
$3.82 from Retrophin, Inc.
Payments received by Dr. Denis Privalov, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!